Newtyn Management’s GeneDx Holdings WGS Stock Holding History

Newtyn Management’s Portfolio WGS Stock Details WGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-51,667	Closed	-$622K	–	77
2023 Q1	$622K	Sell	51,667 -8,939	-15%	-$119K	0.12%	67
2022 Q4	$528K	Buy	60,606 +33,333	+122%	+$734K	0.11%	63
2022 Q3	$790K	Sell	27,273 -7,424	-21%	-$340K	0.17%	61
2022 Q2	$1.44M	Buy	34,697 +16,515	+91%	+$1.12M	0.27%	52
2022 Q1	$1.84M	Buy	+18,182	New	+$2.02M	0.44%	34
2021 Q3	–	Sell	-1,515	Closed	-$701K	–	46
2021 Q2	$701K	Sell	1,515 -1,000	-40%	-$429K	0.19%	56
2021 Q1	$1.24M	Buy	+2,515	New	+$1.31M	0.33%	39

Other funds holding WGS

Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Newtyn Management's WGS Position: Q2 2023 in Review

Newtyn Management sold out of GeneDx Holdings (WGS) in Q2 2023, closing a stake of 51,667 shares — an estimated $622K sold.

Newtyn Management first reported a position in WGS in Q1 2021 and held it in 7 quarters. The position peaked at $1.84M in Q1 2022. 58 funds tracked by Wall St. Rank hold WGS as of Q2 2023.

Newtyn Management reported no remaining GeneDx Holdings position as of Q2 2023 after selling out during the quarter.
Newtyn Management sold 51,667 GeneDx Holdings shares in Q2 2023, an estimated $622K.
Newtyn Management first reported a position in GeneDx Holdings in Q1 2021 and held it in 7 quarters.
Newtyn Management's GeneDx Holdings position peaked at $1.84M in Q1 2022.
58 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2023.

Based on Newtyn Management's 13F filing for Q2 2023, filed 14 Aug 2023.